About Us

Evgen is a clinical stage drug development company focussed on the development of sulforaphane-based compounds, a new class of pharmaceuticals which are synthesised in a proprietary, well-tolerated, stable formulation. 

There is a comprehensive intellectual property package over this technology, covering novel compositions and manufacturing methods. 

Evgen exploits sulforaphane’s activity in three distinct disease-relevant cellular pathways; inhibition of pSTAT3, of importance in controlling cancer metastases, up-regulation of Nrf2, a therapeutic target associated with a broad range of diseases which are characterised by excessive oxidative stress, and inflammation and inhibition of SHP2, a target that has relevance in a number of solid tumours and haematological cancers.
About us rightside pattern
team overlay

Dr Huw Jones, Executive Director

Chief Executive Officer
team overlay

Toni Haenninen

Chief Financial Officer
team overlay

Dr Susan Foden

Interim Non-executive Chairman
team overlay

Dr Alan Barge

Non-executive Director
team overlay

Dr Helen Kuhlman

Chief Business Officer
team overlay

Dr Glen Clack

Chief Medical Officer

Expert Advisors

Consult icon

Dr Mary Stuart - Medical Adviser

Mary is a Pharmaceutical Physician specialising in oncology, with specific expertise in breast cancer and with over two decades of experience in...
Orange Plus Ornge minus
Consult icon

Dr Marjolein Geurts - Scientific Advisor

Marjolein is a neuro-oncologist at Erasmus University Medical Centre. She studied medicine in Utrecht, combining her training as a neurologist with...
Orange Plus Ornge minus
Consult icon

Professor Anthony Chalmers - Scientific and Clinical Advisor

Anthony is Chair of Clinical Oncology at the University of Glasgow and Director of the CRUK RadNet Centre of Excellence in Radiotherapy Research. He...
Orange Plus Ornge minus
Consult icon

Dr Sacha Howell - Scientific and Clinical Advisor

Sacha trained in medicine at Nottingham University and in medical oncology at The Christie NHS Foundation Trust. He gained his PhD in medical...
Orange Plus Ornge minus
Consult icon

Dr Claudio Festuccia - Scientific Advisor

Claudio is a researcher at the University of L’Aquila and is an associate professor in pathology and biology. He started his scientific activity as...
Orange Plus Ornge minus
Consult icon

Professor Phil Eaton - Scientific Advisor

Phil gained a BSc in Biochemistry from Queen Mary College, University of London in 1989 before completing his PhD studies at the University of...
Orange Plus Ornge minus
Consult icon

Professor Rob Clarke - Scientific Advisor

Rob is a Professor of Breast Biology and Director of the Manchester Breast Centre, based at the Oglesby Cancer Research Building. His undergraduate...
Orange Plus Ornge minus
Consult icon

Professor Albena Dinkova-Kostova - Scientific Advisor

Albena is a Professor of Chemical Biology at the Jacqui Wood Cancer Centre, Division of Cellular Medicine, University of Dundee School of Medicine....
Orange Plus Ornge minus